behavior/neurological
|
• heterozygous mice exhibit heightened anxiety in the Open Field Activity test, entering the center of the field 29% less frequently than littermate controls
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Foxq1+ wild type MGI:2436678 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Summary |
17 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• heterozygous mice exhibit heightened anxiety in the Open Field Activity test, entering the center of the field 29% less frequently than littermate controls
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• hemizygous progeny are born at less than one-third the expected Mendelian frequency, most dying by 16.5 days post coitum (16.5 dpc)
|
|
• hemizygous embyros examined at 9.5 dpc often exhibit midline forebrain defects and other aspects of holoprocencephaly
• some hemizygotes that survive to birth exhibit holoprosencephalic phenotypes of varying severity
|
|
• some hemizygous embryos and liveborn pups exhibit structural eye defects
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• almost all mice die before birth, with a significant deviation from expected Mendelian frequencies first noted at E14.5
|
|
• smaller than the pulmonary artery
|
|
• circulatory failure
|
|
• common atrioventricular junction
|
|
• the aorta and pulmonary artery both originate from the right ventricle
|
|
• the mitral valve of E14.5 embryos is dysplastic
|
|
• a primum atrial septal defect is seen at the ventral margin of the primary atrial septum in E14.5 embryos
|
|
• a large ventricular septum defect connects the left and right ventricles
|
|
• kidneys of E14.5 embryos are hypoplastic and occasionally positioned abnormally
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased cumulative center entries in an open field
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
• without micrognathia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• increased activity and center entries in an open field
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• hypoplastic with no development of the interhemispheric fissure
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• hypoplastic with no development of the interhemispheric fissure
|
|
• absence of ear pinnae at E15.5
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
• microagnathia/agnathia
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• lethality occurs in the second half of gestation
|
|
• a single, ventrally displaced eye
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• decreased cumulative center entries in an open field
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice have a 31% decrease compared to controls in how many times the central portion of an open field test is entered
• mice also have additional reductions in total distance traveled (22% decrease) and movement time (14% decrease) in the open field tests
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 01/06/2026 MGI 6.24 |
|
|
|
||


